September 18th, 2014
Do Hemodynamic Endpoints Have Value in Patients Treated for Pulmonary Arterial Hypertension?
Corey E Ventetuolo, MD, MS
Corey E. Ventetuolo discusses her research group’s study of hemodynamic endpoints in clinical trials of patients with pulmonary arterial hypertension.
NEJM Journal Watch — Recent Cardiology Articles- Transcatheter Valve Replacement for Severe Tricuspid Regurgitation
- Time in Blood Pressure Target Range and Outcomes in Hypertension: Real-World Data
- When to Start Anticoagulation After Ischemic Stroke in Patients with Atrial Fibrillation
- Aortic-Valve Replacement vs. Clinical Surveillance for Asymptomatic Severe Aortic Stenosis
- Secondary Hypertension in Young Adults